
New immunotherapy and environmental risks highlight advances in bladder cancer care at AUA 2026.
Research presented at the 2026 American Urological Association Annual Meeting reveals progress in bladder cancer treatment and prevention. Key findings include an immunotherapy drug, durvalumab, combined with standard BCG treatment, which delays dise...


